# A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE

> **NCT03098823** · PHASE4 · COMPLETED · sponsor: **Ampel BioSolutions, LLC** · enrollment: 62 (actual)

## Conditions studied

- Lupus Erythematosus, Systemic
- Lupus Erythematosus
- Fatigue

## Interventions

- **DRUG:** RAYOS
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT03098823
- **Lead sponsor:** Ampel BioSolutions, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-12
- **Primary completion:** 2019-05-28
- **Final completion:** 2020-06-15
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2020-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03098823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03098823, "A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03098823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*